Align Technology has prevailed in a patent infringement lawsuit in China against Angelalign Technology's operating subsidiaries. The Jinan Intermediate People's Court issued a first-instance judgment on August 10, 2026, finding that Angel's use of its MasterForce and ATreat systems to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent CN113693748B. The court ordered Angel to cease using the patented technology and stop manufacturing and selling the infringing products in China, and awarded Align RMB 10 million in damages. Angel may appeal the ruling to the Supreme People's Court, and the appeal deadline has not yet expired. The decision follows other recent enforcement actions, including a preliminary injunction from the Unified Patent Court in February 2026 and an ongoing U.S. International Trade Commission investigation with an initial determination expected in November 2026.
Angelalign Technology IncAngelalign's subsidiaries found to infringe Align's patent, ordered to cease sales and pay damages.
Align Technology IncAlign wins patent infringement case in China, gaining legal protection and damages.
